Form 4: Stryker Corp Executive Robert S Fletcher Acquires Stock Options
SEC Form 4 Filing
Robert S Fletcher, VP and Chief Legal Officer of Stryker Corp, was granted employee stock options on February 5, 2025.
Summary
- Robert S Fletcher, VP, Chief Legal Officer of Stryker Corp, filed a Form 4.
- The filing reports the grant of employee stock options on February 5, 2025.
- Fletcher received options to purchase 7,646 shares of Stryker common stock at an exercise price of $392.39.
- The options vest in five equal installments, with 20% becoming exercisable on each of the first five anniversaries of the grant date.
- Following the transaction, Fletcher directly owns options for 7,646 shares.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The granting of stock options is a standard practice and generally viewed favorably as it aligns executive interests with shareholder value. There are no negative indicators in the filing.
Positives
- The grant of stock options aligns the executive's interests with those of the shareholders, incentivizing performance and long-term value creation.
Future Outlook
The document does not contain any specific forward-looking statements beyond the vesting schedule of the options.
Industry Context
Stock option grants are a common form of executive compensation in the medical technology industry, aligning management's interests with shareholder value.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages in publicly traded companies, particularly in the medical device industry.
- Companies like Medtronic, Johnson & Johnson, and Boston Scientific also utilize stock options as part of their executive compensation plans.
- The vesting schedule of 20% per year over five years is a typical vesting arrangement.
Stakeholder Impact
- Shareholders may view the stock option grant positively as it incentivizes management to improve company performance.
- Employees may see the grant as a sign of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 02/05/2025 | Date of the employee stock option grant. |
| 02/05/2025 | First vesting date of the employee stock options (20%). |
| 02/04/2035 | Expiration date of the employee stock options. |
| 02/07/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Stock Options, Insider Trading, Stryker Corp, Executive Compensation, Robert S Fletcher
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.